Allergan announces FDA approval of label extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus
Co announces approval by the FDA of label extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus based on new clinical data demonstrating that the effects of both products may last for up to one year, which is longer than reported in clinical studies that supported FDA approval of other hyaluronic acid dermal fillers.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters